| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Debt-to-equity | 12.7 | % | +414% |
| Return On Equity | -185 | % | -130% |
| Return On Assets | -164 | % | -109% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 13.1M | shares | +2.31% |
| Common Stock, Shares, Outstanding | 13.1M | shares | +2.31% |
| Entity Public Float | 56.6M | USD | +15% |
| Common Stock, Value, Issued | 13.1K | USD | +2.31% |
| Weighted Average Number of Shares Outstanding, Basic | 13.1M | shares | +2.29% |
| Weighted Average Number of Shares Outstanding, Diluted | 13.1M | shares | +2.29% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | 9.13M | USD | +16.7% |
| General and Administrative Expense | 1.64M | USD | +4.7% |
| Operating Income (Loss) | -10.8M | USD | -14.7% |
| Net Income (Loss) Attributable to Parent | -10.5M | USD | -17.5% |
| Earnings Per Share, Basic | -0.79 | USD/shares | -11.3% |
| Earnings Per Share, Diluted | -0.79 | USD/shares | -5.26% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | 5.82M | USD | -36.3% |
| Assets | 5.83M | USD | -36.3% |
| Accounts Payable, Current | 554K | USD | |
| Employee-related Liabilities, Current | 67.6K | USD | +1.87% |
| Liabilities, Current | 842K | USD | +183% |
| Liabilities | 842K | USD | +183% |
| Retained Earnings (Accumulated Deficit) | -58.1M | USD | -22% |
| Stockholders' Equity Attributable to Parent | 4.98M | USD | -43.7% |
| Liabilities and Equity | 5.83M | USD | -36.3% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -1.78M | USD | -14.5% |
| Net Cash Provided by (Used in) Financing Activities | 299K | USD | |
| Common Stock, Shares Authorized | 100M | shares | 0% |
| Common Stock, Shares, Issued | 13.1M | shares | +2.31% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -1.48M | USD | +4.71% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 5.82M | USD | -36.3% |
| Deferred Tax Assets, Valuation Allowance | 4.51M | USD | +43.6% |
| Deferred Tax Assets, Operating Loss Carryforwards | 4.51M | USD | +43.6% |
| Share-based Payment Arrangement, Expense | 4.22M | USD | +129% |